Conference abstractPublished 2018
Newly approved antimicrobial agents: where do they belong?
The University of Texas, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Antimicrobial resistance remains a global health threat. Judicious use of antimicrobials has been a key strategy in preventing the development of antimicrobial resistance, largely due to the lack of antimicrobial agents needed to treat resistant pathogens. However, several antimicrobial agents have been recently approved with various indications and spectrums of activity. Using these antimicrobial agents inappropriately will contribute to the development of antimicrobial resistance and lead to fewer treatment options in the future. Reviewing the clinical implications for these antimicrobial agents and using them appropriately in the clinical setting is crucial for preventing unintended consequences of antimicrobial use. This presentation will cover the pharmacology, spectra of activity, adverse reactions, drug interactions, and potential role in therapy for each discussed antimicrobial as well as the advantages and disadvantages of these newer antibiotics compared to existing agents.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Sciences & Emerging Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Jonathan Cho”

